Medpace Holdings Statistics
Total Valuation
MEDP has a market cap or net worth of $12.84 billion. The enterprise value is $12.48 billion.
| Market Cap | 12.84B |
| Enterprise Value | 12.48B |
Important Dates
The next estimated earnings date is Monday, April 20, 2026, after market close.
| Earnings Date | Apr 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MEDP has 28.38 million shares outstanding. The number of shares has decreased by -7.77% in one year.
| Current Share Class | 28.38M |
| Shares Outstanding | 28.38M |
| Shares Change (YoY) | -7.77% |
| Shares Change (QoQ) | +0.51% |
| Owned by Insiders (%) | 19.51% |
| Owned by Institutions (%) | 84.55% |
| Float | 22.83M |
Valuation Ratios
The trailing PE ratio is 29.61 and the forward PE ratio is 26.47. MEDP's PEG ratio is 1.98.
| PE Ratio | 29.61 |
| Forward PE | 26.47 |
| PS Ratio | 5.08 |
| Forward PS | 4.43 |
| PB Ratio | 27.97 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 18.83 |
| P/OCF Ratio | 18.01 |
| PEG Ratio | 1.98 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.17, with an EV/FCF ratio of 18.31.
| EV / Earnings | 27.67 |
| EV / Sales | 4.93 |
| EV / EBITDA | 22.17 |
| EV / EBIT | 23.33 |
| EV / FCF | 18.31 |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.30.
| Current Ratio | 0.74 |
| Quick Ratio | 0.69 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 0.23 |
| Debt / FCF | 0.20 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 70.23% and return on invested capital (ROIC) is 354.33%.
| Return on Equity (ROE) | 70.23% |
| Return on Assets (ROA) | 16.40% |
| Return on Invested Capital (ROIC) | 354.33% |
| Return on Capital Employed (ROCE) | 84.68% |
| Weighted Average Cost of Capital (WACC) | 12.14% |
| Revenue Per Employee | $408,102 |
| Profits Per Employee | $72,762 |
| Employee Count | 6,200 |
| Asset Turnover | 1.24 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MEDP has paid $91.25 million in taxes.
| Income Tax | 91.25M |
| Effective Tax Rate | 16.82% |
Stock Price Statistics
The stock price has increased by +38.18% in the last 52 weeks. The beta is 1.46, so MEDP's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | +38.18% |
| 50-Day Moving Average | 512.21 |
| 200-Day Moving Average | 488.76 |
| Relative Strength Index (RSI) | 41.41 |
| Average Volume (20 Days) | 337,070 |
Short Selling Information
The latest short interest is 1.28 million, so 4.52% of the outstanding shares have been sold short.
| Short Interest | 1.28M |
| Short Previous Month | 1.29M |
| Short % of Shares Out | 4.52% |
| Short % of Float | 5.62% |
| Short Ratio (days to cover) | 2.85 |
Income Statement
In the last 12 months, MEDP had revenue of $2.53 billion and earned $451.12 million in profits. Earnings per share was $15.28.
| Revenue | 2.53B |
| Gross Profit | 1.80B |
| Operating Income | 534.94M |
| Pretax Income | 542.38M |
| Net Income | 451.12M |
| EBITDA | 563.06M |
| EBIT | 534.94M |
| Earnings Per Share (EPS) | $15.28 |
Balance Sheet
The company has $497.05 million in cash and $136.85 million in debt, with a net cash position of $360.20 million or $12.69 per share.
| Cash & Cash Equivalents | 497.05M |
| Total Debt | 136.85M |
| Net Cash | 360.20M |
| Net Cash Per Share | $12.69 |
| Equity (Book Value) | 459.07M |
| Book Value Per Share | 16.18 |
| Working Capital | -354.12M |
Cash Flow
In the last 12 months, operating cash flow was $713.22 million and capital expenditures -$31.36 million, giving a free cash flow of $681.87 million.
| Operating Cash Flow | 713.22M |
| Capital Expenditures | -31.36M |
| Depreciation & Amortization | 28.12M |
| Net Borrowing | n/a |
| Free Cash Flow | 681.87M |
| FCF Per Share | $24.03 |
Margins
Gross margin is 71.06%, with operating and profit margins of 21.14% and 17.83%.
| Gross Margin | 71.06% |
| Operating Margin | 21.14% |
| Pretax Margin | 21.44% |
| Profit Margin | 17.83% |
| EBITDA Margin | 22.25% |
| EBIT Margin | 21.14% |
| FCF Margin | 26.95% |
Dividends & Yields
MEDP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.77% |
| Shareholder Yield | 7.77% |
| Earnings Yield | 3.51% |
| FCF Yield | 5.31% |
Analyst Forecast
The average price target for MEDP is $498.25, which is 10.11% higher than the current price. The consensus rating is "Hold".
| Price Target | $498.25 |
| Price Target Difference | 10.11% |
| Analyst Consensus | Hold |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 9.29% |
| EPS Growth Forecast (5Y) | 10.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MEDP has an Altman Z-Score of 6.34 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.34 |
| Piotroski F-Score | 6 |